Leerink Partners Remains Bullish as Fate Therapeutics (FATE) Plans to Initiate ProTmune Study
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Fate Therapeutics (FATE) Tops Q4 EPS by 1c
March 3, 2016 4:15 PM ESTFate Therapeutics (NASDAQ: FATE) reported Q4 EPS of ($0.26), $0.01 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $580 thousand.
Cash and cash equivalents as of December 31, 2015 were $64.8 million, compared to $49.1 million as of December... More
Trading Radar for 3/3: Barnes & Noble (BKS), Ciena (CIEN), HP Enterprise (HPE), H&R Block (HRB), Trina Solar (TSL) Report
March 2, 2016 3:00 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EST
Earnings:
Ability, Inc. (Nasdaq: ABIL) - consensus EPS $0.09
Agenus (Nasdaq: AGEN) - consensus loss $0.17
Alaska Communications Systems (Nasdaq: ALSK) - consensus loss $0.01
Ameresco (Nasdaq:... More
